A comparison of rate control and rhythm control in patients with atrial fibrillation

Cited by (1,006)

Items 801–900 of 1,006

1. Thirty-Day and 1-Year Outcomes of Emergency Department Patients With Atrial Fibrillation and No Acute Underlying Medical Cause
   Frank Xavier Scheuermeyer, Eric Grafstein, Rob Stenstrom, Grant D Innes, Claire Heslop, Jan MacPhee, Reza Pourvali, Brett G. Heilbron, Lorraine McGrath, Jim M. Christenson · 2012 · Annals of Emergency Medicine
2. Dronedarone for Atrial Fibrillation
   David Singh, Eugenio Cingolani, George A. Diamond, Sanjay Kaul · 2010 · Journal of the American College of Cardiology
3. P Wave Dispersion and Left Atrial Appendage Function for Predicting Recurrence after Conversion of Atrial Fibrillation and Relation of P Wave Dispersion to Appendage Function
   Abdullah Doğan, Halil Kahraman, Mustafa Öztürk, Alaettin Avşar · 2004 · Echocardiography
4. Dronedarone: A New Treatment for Atrial Fibrillation
   JAMES C. LAUGHLIN, Peter Russell Kowey · 2008 · Journal of Cardiovascular Electrophysiology
5. Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?
   A. John Camm, Irina Savelieva · 2004 · Heart Rhythm
6. Atrial fibrillation is associated with increased mortality: causation or association?
   Darryl P. Leong, John W. Eikelboom, Jeff S. Healey, Stuart J. Connolly · 2013 · European Heart Journal
7. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation
   MOUSSA C. MANSOUR, Edwin Kevin Heist, Rahul Agarwal, Thomas Jared Bunch, Edward Karst, Jeremy Neil Ruskin, Srijoy Mahapatra · 2018 · The American Journal of Cardiology
8. β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview
   Bramah N. Singh · 2005 · Journal of Cardiovascular Pharmacology and Therapeutics
9. Moderate physical exercise: a simplified approach for ventricular rate control in older patients with atrial fibrillation
   Jurgita Plisienė, A Blumberg, G. Haager, Christian Knackstedt, Joachim Latsch, Christine Norra, M. Arndt, Stefan Tuerk, Nicole Maria Heussen, Malte Kelm et al. · 2008 · Clinical Research in Cardiology
10. Atrial fibrillation and congestive heart failure
    Denis Roy, Mario R. Talajic, Marc Dubuc, Bernard Thibault, Peter G. Guerra, Laurent Macle, Paul Khairy · 2008 · Current Opinion in Cardiology
11. Catheter ablation for atrial fibrillation: Should it be first-line therapy?
    John Marcus Wharton · 2007 · American Heart Journal
12. Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
    William R. Lewis, Gregg C. Fonarow, Kenneth A. LaBresh, Christopher Paul Cannon, Wenqin Pan, Dennis M. Super, Suzanne A. Sorof, Lee H. Schwamm · 2008 · The American Journal of Cardiology
13. Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role
    Teresa Maria Seccia, Brasilina Caroccia, María Lorenza Muiesan, Gian Paolo Rossi · 2016 · International Journal of Cardiology
14. Atria-selective antiarrhythmic drugs in need of alliance partners
    Rémi Peyronnet, Ursula Ravens · 2019 · Pharmacological Research
15. Early atrial fibrillation detection and the transition to comprehensive management
    Dominik Linz, Astrid N L Hermans, Robert G. Tieleman · 2020 · EP Europace
16. Baseline data in clinical trials
    David Burgess, Val Gebski, ANTHONY C. KEECH · 2003 · The Medical Journal of Australia
17. Patient knowledge of atrial fibrillation: 3‐month follow‐up after an emergency room visit
    Leena Koponen, Leena Rekola, Taru Ruotsalainen, Mika Lehto, Helena Leino‐Kilpi, Liisa‐Maria Voipio‐Pulkki · 2007 · Journal of Advanced Nursing
18. Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
    Apurva Omkar Badheka, Nileshkumar Patel, Peeyush M. Grover, Neeraj Nailesh Shah, Nilay Patel, Vikas Singh, Abhishek J. Deshmukh, Kathan Dilipbhai Mehta, Ankit Chothani, Ghanshyambhai Tulsibhai Savani et al. · 2014 · The American Journal of Cardiology
19. Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation
    Jeffrey W. Holmes, Zachary Laksman, Lior Gepstein · 2015 · Progress in Biophysics and Molecular Biology
20. Nonchannel drug targets in atrial fibrillation
    Andreas Goette, Uwe Lendeckel · 2004 · Pharmacology & Therapeutics
21. Power supplies for cardiovascular implantable electronic devices
    Jue Deng, Xuemei Sun, Huisheng Peng · 2023 · EcoMat
22. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
    Oksana M. Drapkina, Концевая Анна Васильевна, А. М. Калинина, Sergey Nikolaevich Avdeev, Агальцов Михаил Викторович, Л. И. Алексеева, I. I. Almazova, Е. Yu. Andreenko, D. N. Antipushina, Yu. А. Balanova et al. · 2024 · CARDIOVASCULAR THERAPY AND PREVENTION
23. Effect of Bucindolol on Heart Failure Outcomes and Heart Rate Response in Patients with Reduced Ejection Fraction Heart Failure and Atrial Fibrillation
    David Peter Kao, Gordon W. Davis, Ryan G. Aleong, Christopher M. O’Connor, Mona Fiuzat, Peter E. Carson, Inder S. Anand, Jonathan F. Plehn, Stephen S. Gottlieb, Marc A. Silver et al. · 2012 · European Journal of Heart Failure
24. Dronedarone: A New Antiarrhythmic Agent
    Ola O. Oyetayo, Carrie E. Rogers, Prudence O. Hofmann · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
25. Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias
    Kim Hoe Chan, Ian Wilcox · 2010 · Expert Review of Cardiovascular Therapy
26. Advanced Left Atrial Remodeling and Appendage Contractile Dysfunction in Women Than in Men Among the Patients With Atrial Fibrillation: Potential Mechanism for Stroke
    Hee Tae Yu, Jihei Sara Lee, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Geu‐Ru Hong, Moon‐Hyoung Lee, Chi Young Shim, Hui‐Nam Pak · 2016 · Journal of the American Heart Association
27. Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Jonathan M. Kalman, Prashanthan Sanders, Raphaël Rosso, Hugh G Calkins · 2017 · Circulation
28. The role of the gap junction perinexus in cardiac conduction: Potential as a novel anti-arrhythmic drug target
    Daniel T. Hoagland, Webster L. Santos, Steven Poelzing, Robert G. Gourdie · 2018 · Progress in Biophysics and Molecular Biology
29. Sex differences in arrhythmias
    Abel Rivero, Anne B. Curtis · 2009 · Current Opinion in Cardiology
30. The Systematic Guideline Review: Method, rationale, and test on chronic heart failure
    Christiane Muth, Jochen Stefan Gensichen, Martin Beyer, Allen Hutchinson, Ferdinand Michael Gerlach · 2009 · BMC Health Services Research
31. Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia
    Bethan Freestone, Ratna Rajaratnam, N. Hussain, Gregory Y.H. Lip · 2003 · International Journal of Cardiology
32. Atrial-selective sodium channel block for the treatment of atrial fibrillation
    Alexander Burashnikov, Charles N Antzelevitch · 2009 · Expert Opinion on Emerging Drugs
33. The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion
    Osnat T. Gurevitz, Chitra J. Varadachari, Naser M. Ammash, Joseph F. Malouf, A. Gabriela Rosales, Regina M. Herges, Charles J. Bruce, Virend Kristen Somers, Stephen C. Hammill, Bernard John Gersh et al. · 2006 · American Heart Journal
34. Atrial Fibrillation
    Amy L. Valderrama, Sandra Barker Dunbar, George A. Mensah · 2005 · American Journal of Preventive Medicine
35. In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate
    Christopher P. Regan, Audrey A. Wallace, Hillary K. Cresswell, Charity L. Atkins, Joseph J. Lynch · 2006 · Journal of Pharmacology and Experimental Therapeutics
36. Clustering of RR Intervals Predicts Effective Electrical Cardioversion for Atrial Fibrillation
    Maarten P. van den Berg, Trudeke Van Noord, JAN BROUWER, J. Haaksma, Dirk Jan van Veldhuisen, Harry J.G.M. Crijns, Isabelle C. Van Gelder · 2004 · Journal of Cardiovascular Electrophysiology
37. Clinical Trials Update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and Percutaneous Mitral Annuloplasty
    John G.F. Cleland, Alison P. Coletta, Ahmed Tageldien Abdellah, Mansoor Nasir, Neil A Hobson, Nick Freemantle, Andrew L. Clark · 2006 · European Journal of Heart Failure
38. A retrospective evaluation of transthoracic biphasic electrical cardioversion for atrial fibrillation in dogs
    Janice M. Bright, Julie Martin, Khursheed R. Mama · 2005 · Journal of Veterinary Cardiology
39. Progression to the Persistent Form in Asymptomatic Paroxysmal Atrial Fibrillation
    Keitaro Senoo, Shinya S. Suzuki, Takayuki Otsuka, Koichi Sagara, Shunsuke Matsuno, Hiroto Kano, Tokuhisa Uejima, Yuji Oikawa, Junji Yajima, Kazuyuki Nagashima et al. · 2014 · Circulation Journal
40. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS)
    Avraham Shotan, Moshe Garty, D. S. Blondhein, Simcha Ron Meisel, B. S. Lewis, Michael Kleiner Shochat, Ehud Grossman, A. Porath, V. Boyko, Reuven Zimlichman et al. · 2009 · European Heart Journal
41. Incidence and Predictors of Pacemaker Placement After Surgical Ablation for Atrial Fibrillation
    Berhane Worku, Sang‐Woo Pak, Faisal Habib Cheema, Mark J. Russo, Brian Housman, Danielle Van Patten, Jessica Harris, Michael Argenziano · 2011 · The Annals of Thoracic Surgery
42. Prevalence of auricular thrombosis before atrial flutter cardioversion: a 17-year transoesophageal echocardiographic study
    Alberto Cresti, Miguel Ángel García Fernández, Francesco De Sensi, Gennaro Miracapillo, Andréa Picchi, Marco Scalese, Silva Severi · 2015 · EP Europace
43. Catheter Ablation for Atrial Fibrillation
    Stuart P. Thomas, Prashanthan Sanders · 2012 · Heart Lung and Circulation
44. In vitro and In vivo Relevance of the P-glycoprotein Probe Substrates in Drug Discovery and Development: Focus on Rhodamine 123, Digoxin and Talinolol
    Ana C. Fortuna, Gilberto Alves, Amílcar C. Falcão · 2011 · Journal of Bioequivalence & Bioavailability
45. Angiographic profile and outcomes in persistent non-valvular atrial fibrillation: A study from tertiary care center in North India
    Yash Paul Sharma, Akash Batta, Kunaal Makkar, Juniali Hatwal, Atit A Gawalkar, Navjyot Kaur, Tejinder Singh Malhi, Ganesh Kasinadhuni, Himanshu Gupta, Prashant Kumar Panda et al. · 2021 · Indian Heart Journal
46. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction
    Ole Dyg Pedersen, Henning Bagger, Lars Køber, Christian Tobias Torp-Pedersen · 2005 · International Journal of Cardiology
47. Does Conversion and Prevention of Atrial Fibrillation Enhance Survival in Patients with Left Ventricular Dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) Study
    Ole Dyg Pedersen, Bente Brendorp, Hanne Elming, Steen Michael Pehrson, Lars Køber, Christian Tobias Torp-Pedersen · 2003 · Cardiac Electrophysiology Review
48. Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)
    Jason G. Andrade, Stuart J. Connolly, Paul Dorian, Martin S. Green, Karin H. Humphries, George Joseph Klein, Robert S. Sheldon, Mario R. Talajic, Charles R. Kerr · 2010 · Heart Rhythm
49. Favorable Long-Term Outcome of Maze Surgery in Patients With Lone Atrial Fibrillation
    Martin E.W. Hemels, Youlan L. Gu, Anton E. Tuinenburg, Piet Willem Boonstra, Ans C.P. Wiesfeld, Maarten P. van den Berg, Dirk Jan van Veldhuisen, Isabelle C. Van Gelder · 2006 · The Annals of Thoracic Surgery
50. Role of oral anticoagulation in management of atrial fibrillation
    Eugene Crystal, Stuart J. Connolly · 2004 · Heart
51. Bicarbonate therapy for unstable propafenone-induced wide complex tachycardia
    Jeffrey Reynold Brubacher · 2004 · Canadian Journal of Emergency Medicine
52. AFFIRM and RACE Trials: Implications for the Management of Atrial Fibrillation
    Joseph L. Blackshear, Robert E. Safford · 2003 · Cardiac Electrophysiology Review
53. Management of Patients With Atrial Fibrillation by Primary‐Care Physicians in Germany: 1‐Year Results of the <scp>ATRIUM</scp> Registry
    Kirchhof, Paulus, Schmalowsky, Janine, Pittrow, David, Rosin, Ludger, Kirch, Wilhelm, Wegscheider, Karl, Meinertz, Thomas, for the ATRIUM Study Group · 2014 · Clinical Cardiology
54. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation
    Daniele Pastori, Alessio Farcomeni, Tommaso Bucci, Roberto Cangemi, Paolo Ciacci, Tommasa Vicario, Francesco Violi, Pasquale Pignatelli · 2014 · International Journal of Cardiology
55. 2025 Clinical practice guidelines for Atrial fibrillation and flutter
    Elena Zelikovna Golukhova, Golitsyn Sp, Е. Н. Михайлов, A.S.h. Revishvili, Mari G. Arakelyan, E. Yu. Vasilyeva, Karapet V. Davtyan, Oksana M. Drapkina, L. Yu. Drozdova, Кропачева Екатерина Станиславовна et al. · 2026 · Russian Journal of Cardiology
56. Quality of Life Variables in the Selection of Rate Versus Rhythm Control in Patients with Atrial Fibrillation: Observations from the Canadian Trial of Atrial Fibrillation
    Paul Dorian, Iqwal Mangat · 2003 · Cardiac Electrophysiology Review
57. The burden of atrial fibrillation in the Netherlands
    Harald E. Heemstra, Robby Nieuwlaat, M. Meijboom, Harry J.G.M. Crijns · 2011 · Netherlands Heart Journal
58. Acupuncture for paroxysmal and persistent atrial fibrillation: An effective non-pharmacological tool?
    Federico Lombardi · 2012 · World Journal of Cardiology
59. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey
    Trang Dinh, Robby Nieuwlaat, Robert G. Tieleman, Harry Roger Buller, Nico A. Mensing van Charante, Martin H. Prins, Harry J.G.M. Crijns · 2007 · International Journal of Clinical Practice
60. Aging is a primary risk factor for cardiac arrhythmias: disruption of intracellular Ca2+regulation as a key suspect
    Fiona Hatch, Matthew Kenneth Lancaster, Sandra A. Jones · 2011 · Expert Review of Cardiovascular Therapy
61. Comparison of Mortality and Morbidity in Patients With Atrial Fibrillation and Heart Failure With Preserved Versus Decreased Left Ventricular Ejection Fraction
    M.D. Cheitlin · 2012 · Yearbook of Cardiology
62. Complex Network Clustering by a Multi-objective Evolutionary Algorithm Based on Decomposition and Membrane Structure
    Ying Ju, Songming Zhang, Ningxiang Ding, Xiangxiang Zeng, Xingyi Zhang · 2016 · Scientific Reports
63. Surgery for atrial fibrillation
    Richard Lee, Jane T. Kruse, Patrick M. McCarthy · 2009 · Nature Reviews Cardiology
64. Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation
    Nandini Madan, Sanjeev V. Saksena · 2004 · The American Journal of Cardiology
65. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study
    S. S. Andersen, M. L. Hansen, Gunnar Gislason, T. K. Schramm, Fredrik Folke, Emil Loldrup Fosbøl, Steen Zabell Abildstrom, M. Madsen, Lars Køber, Christian Tobias Torp-Pedersen · 2009 · EP Europace
66. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study
    George H. Crossley, Andrew Boyle, Holly S. Vitense, Lou Sherfesee, R. Hardwin Mead · 2008 · American Heart Journal
67. Atrial fibrillation as a complication of dengue hemorrhagic fever: non-self-limiting manifestation
    Masliza Mahmod, Noor Darinah Mohd Darul, Ibtisam Mokhtar, Norazirah Md Nor, Fauzi Md. Anshar, Oteh Maskon · 2009 · International Journal of Infectious Diseases
68. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events
    Henrik Almroth, Tommy Andersson, Espen Fengsrud, Leif Friberg, P. Linde, Mårten Rosenqvist, Anders Englund · 2011 · Journal of Internal Medicine
69. The RACE Study in Perspective of Randomized Studies on Management of Persistent Atrial Fibrillation
    Vincent E. Hagens, Isabelle C. Van Gelder, Harry J.G.M. Crijns · 2003 · Cardiac Electrophysiology Review
70. Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation
    Trudeke Van Noord, Harry J.G.M. Crijns, Maarten P. van den Berg, Dirk Jan van Veldhuisen, Isabelle C. Van Gelder · 2005 · BMC Cardiovascular Disorders
71. Warfarin for atrial fibrillation: the end of an era?
    Geoffrey Alan Donnan, Helen Margaret Dewey, B.R. Chambers · 2004 · The Lancet Neurology
72. Rate versus Rhythm Control in Patients with Atrial Fibrillation
    Harry J.G.M. Crijns · 2005 · Drugs
73. Management of Atrial Fibrillation — Radical Reform or Modest Modification?
    Rodney H. Falk · 2002 · New England Journal of Medicine
74. SYSTEMATIC REVIEW: Surgical Maze Procedure as a Treatment for Atrial Fibrillation: A Meta‐Analysis of Randomized Controlled Trials
    Melissa H. Kong, Renato D. Lópes, Jonathan Paul Piccini, Vic Hasselblad, Tristram D. Bahnson, Sana M. Al‐Khatib · 2010 · Cardiovascular Therapeutics
75. Strokes after cardioversion of atrial fibrillation — The FibStroke study
    Antti Palomäki, Pirjo E. Mustonen, Juha E.K. Hartikainen, Ilpo O. Nuotio, Tuomas Kiviniemi, Antti Ylitalo, Päivi H. Hartikainen, Heidi Lehtola, Riho Luite, Juhani K.E. Airaksinen · 2015 · International Journal of Cardiology
76. Safety of Dronedarone in Routine Clinical Care
    Leif Friberg · 2014 · Journal of the American College of Cardiology
77. Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation
    Ken Kato, T. Fujimaki, Tomohiro Yoshida, M. Oguri, Kazuhiro Yajima, T. Hibino, Toyoaki Murohara · 2009 · EP Europace
78. Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes
    James W.W. Wong, Koon‐Hou Mak · 2006 · The Annals of Thoracic Surgery
79. Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation
    Gregory Y.H. Lip, Deirdre A. Lane, Harry Roger Buller, Stavros Z. Apostolakis · 2013 · CHEST Journal
80. Management of Atrial Fibrillation in the Year 2033: New Concepts, Tools, and Applications Leading to Personalized Medicine
    Anne M. Gillis, Andrew David Krahn, Allan Cameron Skanes, Stanley Nattel · 2013 · Canadian Journal of Cardiology
81. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation
    Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Gregory Y.H. Lip · 2017 · Hypertension
82. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF
    Jeffrey B. Washam, DaJuanicia N. Holmes, Laine Elliott Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard John Gersh, Peter Russell Kowey, Jack Ansell et al. · 2018 · Journal of the American Heart Association
83. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall‐Related Injuries and Syncope
    Frederik Dalgaard, Jannik Langtved Pallisgaard, Anna‐Karin Numé, Tommi Bo Lindhardt, Gunnar Gislason, Christian Tobias Torp-Pedersen, Martin Huth Ruwald · 2019 · Journal of the American Geriatrics Society
84. Atrial Fibrillation: Current Evidence and Management Strategies During the Perioperative Period
    Kunal Karamchandani, Ashish Kumar Khanna, Somnath Bose, Rohesh J. Fernando, Allan J. Walkey · 2019 · Anesthesia & Analgesia
85. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy
    Jason G. Andrade, Denis Roy, D. George Wyse, Jean‐Claude Tardif, Mario R. Talajic, Hugues Leduc, Julia Cadrin‐Tourigny, Azadeh Shohoudi, Marc Dubuc, Léna Rivard et al. · 2015 · Heart Rhythm
86. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.
    David E. Bush, Lisa Warsinger Martin, Robert B. Leman, Mary L. Chandler, L. Julian Haywood · 2006 · PubMed Central
87. Management of atrial fibrillation—
    Renato Pietro Ricci, Maurizio Russo, Massimo Santini · 2006 · Clinical Research in Cardiology
88. Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
    Sana M. Al‐Khatib, Linda K. Shaw, Kerry L. Lee, Christopher J. O’Connor, Robert M. Califf · 2004 · The American Journal of Cardiology
89. Management of atrial fibrillation
    Ahmad Salah Hersi, D. George Wyse · 2005 · Current Problems in Cardiology
90. Obliteration of the leftatrial appendage forprevention of thromboembolism**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
    Jonathan L. Halperin, Mardi Gomberg‐Maitland · 2003 · Journal of the American College of Cardiology
91. Targeted pharmacological reversal of electrical remodeling after cardioversion—Rationale and design of the Flecainide Short-Long (Flec-SL) trial
    Paulus F. Kirchhof, Thomas Fetsch, Peter Hanrath, Thomas Meinertz, Gerhard Steinbeck, Walter Lehmacher, GÜNTER E. BREITHARDT · 2005 · American Heart Journal
92. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly
    Elesber, Ahmad A., Rosales, Ana Gabriela, Herges, Regina M., Shen, Win-Kuang, Moon, Brenda S., Malouf, Joseph F., Ammash, Naser M., Somers, Virend, Hodge, David O., Gersh, Bernard J. et al. · 2006 · European Heart Journal
93. Pharmacological cardioversion for atrial fibrillation and flutter
    John Cordina, Gillian Elizabeth Mead · 2005 · Cochrane Database of Systematic Reviews · Retracted
94. Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials
    Daniel Caldeira, Cláudio David, Cristina Sampaio · 2011 · European Journal of Internal Medicine
95. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF)
    Fredrik Holmqvist, DaJuanicia N. Simon, Benjamin Adam Steinberg, Seok Jae Hong, Peter Russell Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul Chang, Bernard John Gersh, Eric David Peterson et al. · 2015 · Journal of the American Heart Association
96. Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation
    Manabu Taniguchi, Teiji Akagi, Shinichi Ohtsuki, Yoshio Okamoto, Yasuharu Tanabe, Nobuhisa Watanabe, Koji Nakagawa, Norihisa Toh, KENGO FUKUSHIMA KUSANO, Shunji Sano · 2008 · Catheterization and Cardiovascular Interventions
97. A review on dronedarone: Pharmacological, pharmacodynamic and pharmacokinetic profile
    Farah Iram, Sadaf Ali, Aftab Ahmad, Shah Alam Khan, Asif Husain · 2016 · Journal of Acute Disease
98. Update on atrial fibrillation
    Amanulla Khaji, Peter Russell Kowey · 2016 · Trends in Cardiovascular Medicine
99. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
    Nelson Telles-Garcia, Khagendra B. Dahal, Cyrus Kocherla, Gregory Y.H. Lip, Pratap C Reddy, Paari S. Dominic · 2018 · International Journal of Cardiology
100. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database
     Stefan Hans Hohnloser, Edin Basic, Michael Näbauer · 2019 · Clinical Research in Cardiology